Q3 2025 Management View John Treace, Founder, Chairman & CEO, reported third quarter revenues of $50.2 million, representing 11% growth over the third quarter of 2024 and a 49% improvement in adjusted ...
Third quarter 2025 net loss was $ (16.3) million, or $ (0.26) per share, compared to $ (15.4) million, or $ (0.25) per share, for the same period in 2024. Adjusted EBITDA loss was $ (2.6) million in ...
Get the latest analysis on Heron Therapeutics (HRTX): current challenges, future outlook, and key growth factors. Click here ...
Pulse Biosciences ( PLSE 3.81%) reported its first revenues, marking initial commercial adoption of its nPulse platform and ...
STAAR Surgical Company 25510 Commercentre Drive Lake Forest, CA 92630 Dear Members of the Board: I congratulate the Board on STAAR Surgical's strong results for the third quarter ended September 26, ...
Full-year 2025 guidance -- Revenue expected between $365 million-$375 million, non-GAAP gross margins of 78%-80%, non-GAAP ...
Effective cash management helps businesses and nonprofits stay agile, cover expenses, and invest for the future. Sitting on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback